We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-4.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$45.6B
AUM Growth
-$127M
Cap. Flow
+$2.53B
Cap. Flow %
5.54%
Top 10 Hldgs %
23.21%
Holding
1,436
New
36
Increased
871
Reduced
416
Closed
40

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$320M
2
SCHW
Charles Schwab
SCHW
+$184M
3
ASML icon
ASML
ASML
+$182M
4
MKTX icon
MarketAxess Holdings
MKTX
+$182M
5
CTVA icon
Corteva
CTVA
+$178M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$176M
2
META icon
Meta Platforms (Facebook)
META
+$175M
3
ADBE icon
Adobe
ADBE
+$169M
4
NOW icon
ServiceNow
NOW
+$153M
5
INTU icon
Intuit
INTU
+$147M

Sector Composition

Rank Sector Weight
1 Technology 29.71%
2 Materials 29.09%
3 Healthcare 8.37%
4 Financials 8.1%
5 Energy 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQC
1301
DELISTED
Equity Commonwealth
EQC
$38K ﹤0.01%
+2,077
New +$40.3K
AZPN
1302
DELISTED
Aspen Technology Inc
AZPN
$37K ﹤0.01%
182
LMNR icon
1303
Limoneira
LMNR
$239M
$36K ﹤0.01%
2,368
SENEA icon
1304
Seneca Foods Class A
SENEA
$1.15B
$36K ﹤0.01%
661
DNA icon
1305
Ginkgo Bioworks
DNA
$584M
$35K ﹤0.01%
485
OMCL icon
1306
Omnicell
OMCL
$1.71B
$35K ﹤0.01%
788
SWX icon
1307
Southwest Gas
SWX
$6.5B
$35K ﹤0.01%
579
+1
+0.2% +$64
BPMC
1308
DELISTED
Blueprint Medicines
BPMC
$34K ﹤0.01%
679
CWEN icon
1309
Clearway Energy Class C
CWEN
$4.99B
$34K ﹤0.01%
1,609
+109
+7% +$2.77K
GNRC icon
1310
Generac Holdings
GNRC
$11.9B
$34K ﹤0.01%
310
LKFT
1311
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
$33K ﹤0.01%
956
NGVC icon
1312
Vitamin Cottage Natural Grocers
NGVC
$765M
$31K ﹤0.01%
2,390
UAN icon
1313
CVR Partners
UAN
$1.33B
$31K ﹤0.01%
381
+19
+5% +$1.57K
CNS icon
1314
Cohen & Steers
CNS
$4.35B
$30K ﹤0.01%
481
-4
-0.8% -$253
GLOB icon
1315
Globant
GLOB
$1.6B
$29K ﹤0.01%
145
-197
-58% -$36.9K
MORT icon
1316
VanEck Mortgage REIT Income ETF
MORT
$379M
$29K ﹤0.01%
2,556
PACB icon
1317
Pacific Biosciences
PACB
$441M
$29K ﹤0.01%
3,493
+374
+12% +$4.27K
HYD icon
1318
VanEck High Yield Muni ETF
HYD
$4.42B
$28K ﹤0.01%
570
+5
+0.9% +$253
ITM icon
1319
VanEck Intermediate Muni ETF
ITM
$2.14B
$28K ﹤0.01%
640
+3
+0.5% +$136
FPI
1320
Farmland Partners
FPI
$418M
$27K ﹤0.01%
2,592
-97
-4% -$1.11K
LXU icon
1321
LSB Industries
LXU
$707M
$27K ﹤0.01%
2,657
-270
-9% -$2.8K
NOVT icon
1322
Novanta
NOVT
$5.28B
$27K ﹤0.01%
185
BEAM icon
1323
Beam Therapeutics
BEAM
$2.67B
$26K ﹤0.01%
1,088
BEP icon
1324
Brookfield Renewable
BEP
$10.2B
$26K ﹤0.01%
1,200
GRWG icon
1325
GrowGeneration
GRWG
$88.3M
$26K ﹤0.01%
8,756

Similar funds

VanEck Associates's Q3 2023 Portfolio in Review

As of Q3 2023, VanEck Associates held 1,436 positions worth $45.6B, down 0.28% from $45.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

VanEck Associates deployed $2.53B of net new capital in Q3 2023, opening 36 new positions and adding to 871 existing holdings. Its largest new stake was Weatherford International: 1,266,800 shares worth $114M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Materials and Healthcare.

On the sell side, the largest reduction was Lam Research, an estimated $176M trimmed.

  • VanEck Associates's largest Q3 2023 buy was Weatherford International: 1,266,800 shares worth $114M.
  • VanEck Associates added most to TSMC in Q3 2023, an estimated $320M increase.
  • VanEck Associates's biggest Q3 2023 reduction was Lam Research, cutting an estimated $176M.
  • VanEck Associates fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q3 2023, selling an estimated $45.6M.
  • VanEck Associates's ten largest holdings make up 23% of its $45.6B portfolio in Q3 2023.
  • VanEck Associates opened 36 new positions and closed 40 in Q3 2023.
  • VanEck Associates's portfolio value fell 0.28% quarter-over-quarter to $45.6B.

Based on VanEck Associates's 13F filing for Q3 2023, filed 8 Nov 2023.